Postpartum course in women with preexisting panic disorder

Area of Science:

• Psychiatry
• Perinatal Mental Health
• Anxiety Disorders

Background:

• The postpartum period is recognized as a critical time for the onset or exacerbation of psychiatric disorders.
• The specific impact of the postpartum period on the clinical course of pre-existing anxiety disorders, particularly panic disorder, remains undercharacterized.
• This study focuses on the postpartum psychiatric course of women with a history of panic disorder.

Purpose of the Study:

• To characterize the clinical course of panic disorder during the postpartum period in women with pre-existing condition.
• To identify factors influencing the course of anxiety disorders in the puerperium.
• To evaluate the potential prophylactic role of early pharmacotherapy.

Main Methods:

• Retrospective chart review and interviews were used to assess 40 women with pregravid panic disorder.
• Clinical course, including illness severity and treatment, was evaluated from the third trimester of pregnancy through the first 12 weeks postpartum.
• Statistical analysis was performed to determine the significance of treatment on postpartum outcomes.

Main Results:

• A significant proportion of women (35%) experienced a worsening of their panic disorder symptoms during the postpartum period.
• Conversely, 65% of participants either maintained their clinical status or showed improvement.
• Women who received pharmacotherapy by the third trimester of pregnancy were significantly less likely to experience postpartum worsening of anxiety compared to those who did not (p < .0001).

Conclusions:

• The postpartum period represents a significant risk for the exacerbation of panic disorder in some women.
• Prophylactic use of antipanic medication prior to delivery may be beneficial for women at higher risk of postpartum anxiety.
• Early intervention with pharmacotherapy could mitigate the risk of puerperal worsening of anxiety disorders.